Tag Archives: U.S.

With U.S. elections nearing, European pharma giants brace for potential pricing action: analysts

With U.S. presidential and congressional campaigns in full swing, it’s not just Americans anxiously awaiting the results of the upcoming elections. The races could affect European pharma companies in a big way, and now ODDO BHF analysts are laying out potential ramifications for the industry there.  Amid the intense campaigning by both parties, the “usual package of measures” on drug pricing and insurance has surfaced,… Read More »

AstraZeneca, Emergent BioSolutions sign $87M deal to produce U.S. supply of COVID-19 vaccine

AstraZeneca made waves last week when it signed a massive $ 750 million deal to ramp production of a University of Oxford COVID-19 vaccine up to 2 billion doses per year. Now, as part of a Trump administration effort to get shots into U.S. hands as soon as possible, AstraZeneca has agreed to another major… Read More »

States Mull Reopening as U.S. Coronavirus Cases Pass 728,000

SUNDAY, April 19, 2020 — As governors across America crafted plans to start easing social distancing amid the coronavirus pandemic, U.S. cases topped 728,000 on Sunday while the death toll neared 35,000. But new estimates from Harvard University researchers suggest the United States as a whole cannot safely reopen unless health officials triple the number… Read More »